OVID Ovid Therapeutics

Ovid Therapeutics to Host Educational Webinar on Angelman Syndrome and OV101 Development Program

Ovid Therapeutics to Host Educational Webinar on Angelman Syndrome and OV101 Development Program
EN
14/10/2020

Underlying

OVIDOvid Therapeutics

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on Ovid Therapeutics

Wedbush Research
  • Wedbush Research
WDC WESTERN DIGITAL CORPORATION
SIMON SILICON MOTION TECHNOLOGY CORPORATION SPONSORED ADR
PSTG PURE STORAGE INC. CLASS A
NVDA NVIDIA CORPORATION
NTAP NETAPP INC.
MU MICRON TECHNOLOGY INC.
INTC INTEL CORPORATION
GOOGL ALPHABET INC. CLASS A
FB FACEBOOK INC. CLASS A
AXTI AXT INC.
ARDX ARDELYX INC
2330 TAIWAN SEMICONDUCTOR MANUFACTURING CO. LTD.
2303 UNITED MICROELECTRONICS CORP.
OVID OVID THERAPEUTICS
AMZN AMAZON.COM INC.
AMD ADVANCED MICRO DEVICES INC.
AAPL APPLE INC.
MSFT MICROSOFT CORPORATION
HOV HOVNANIAN ENTERPRISES INC. CLASS A
STOK STOKE THERAPEUTICS
SMCI SUPER MICRO COMPUTER
LRMR INC.
TVTX LARIMAR THERAPEUTICS INC
VRDN TRAVERE THERAPEUTICS INC
STX VIRIDIAN THERAPEUTICS INC
ATXS SEAGATE TECHNOLOGY HLDGS PLC
GFS ASTRIA THERAPEUTICS INC
SLDB GLOBALFOUNDRIES INC
DNTH SOLID BIOSCIENCES INC
TLX DIANTHUS THERAPEUTICS INC
MAZE TELIX PHARMACEUTICALS LIMITED
BBOT MAZE THERAPEUTICS INC
BRIDGEBIO ONCOLOGY THERAPEUTICS
08/18/25 August 18, 2025 1 EN
Laura Chico
  • Laura Chico
ARDX ARDELYX INC
OVID OVID THERAPEUTICS
STOK STOKE THERAPEUTICS
LRMR LARIMAR THERAPEUTICS INC
TVTX TRAVERE THERAPEUTICS INC
VRDN VIRIDIAN THERAPEUTICS INC
ATXS ASTRIA THERAPEUTICS INC
SLDB SOLID BIOSCIENCES INC
DNTH DIANTHUS THERAPEUTICS INC
MAZE MAZE THERAPEUTICS INC
08/18/25 August 18, 2025 1 EN
Wedbush Research
  • Wedbush Research
W WAYFAIR INC.
SHOP SHOPIFY INC.
WDC WESTERN DIGITAL CORPORATION
TRIP TRIPADVISOR INC.
SIMON SILICON MOTION TECHNOLOGY CORPORATION SPONSORED ADR
PSTG PURE STORAGE INC. CLASS A
NVDA NVIDIA CORPORATION
NTAP NETAPP INC.
MU MICRON TECHNOLOGY INC.
MELI MERCADOLIBRE INC.
INTC INTEL CORPORATION
GOOGL ALPHABET INC. CLASS A
FB FACEBOOK INC. CLASS A
EXPE EXPEDIA GROUP INC.
ETSY ETSY INC.
EBAY EBAY INC.
AXTI AXT INC.
WD WALKER & DUNLOP INC.
2330 TAIWAN SEMICONDUCTOR MANUFACTURING CO. LTD.
2303 UNITED MICROELECTRONICS CORP.
CVNA CARVANA CO. CLASS A
OVID OVID THERAPEUTICS
SE SEA ADS
AMZN AMAZON.COM INC.
AMD ADVANCED MICRO DEVICES INC.
AAPL APPLE INC.
MSFT MICROSOFT CORPORATION
BKNG BOOKING HOLDINGS INC.
LYFT LYFT
PINS PINTEREST INC. CLASS A
UBER UBER TECHNOLOGIES INC.
FMCC FEDERAL HOME LOAN MORTGAGE CORPORATION
SMCI SUPER MICRO COMPUTER
DASH INC.
ABNB DOORDASH
PLTR AIRBNB INC. CLASS A
BUR PALANTIR TECHNOLOGIES
FNMA BURFORD CAPITAL
XMTR FEDERAL NATIONAL MORTGAGE ASSOCIATION
XOS XOMETRY
STX INC.
TTD XOS INC.
GFS SEAGATE TECHNOLOGY HLDGS PLC
CINT THE TRADE DESK
YOU INC.
RUM GLOBALFOUNDRIES INC
ALCC CI&T INC
CART CLEAR SECURE INC
ANRO RUMBLE INC
JBIO ALTC ACQUISITION CORP
MAPLEBEAR INC.
ALTO NEUROSCIENCE INC
JADE BIOSCIENCES INC
08/14/25 August 14, 2025 1 EN
Laura Chico
  • Laura Chico
OVID OVID THERAPEUTICS
08/13/25 August 13, 2025 1 EN
 PRESS RELEASE
Free
OVID Ovid Therapeuti...

Ovid Therapeutics Reports Business Updates and Second Quarter 2025 Fin...

Ovid Therapeutics Reports Business Updates and Second Quarter 2025 Financial Results Topline results from the OV329 Phase 1 safety, tolerability and biomarker study remain on track for a readout in Q3 2025$7.0 million royalty monetization agreement signed with Immedica Pharma AB for future ganaxolone royalties, delivering capital to the Company from a non-pipeline assetOV4071, the first ever oral KCC2 direct activator, is completing an IND-enabling package; Ovid anticipates first-in-human studies in Q2 2026Cash, cash equivalents and marketable securities of $38.3 million as of June 30, 2025...

August 13, 2025 1 EN

ResearchPool Subscriptions

Get the most out of your insights

Get in touch